FDA: AuroMedics recalls one lot of Levofloxacin
Editor's Note
The Food & Drug Administration (FDA) on January 18 announced the recall by AuroMedics (East Windsor, New Jersey) of one lot of Levofloxacin in 5% Dextrose Injection 250 mg/50 mL in a single-use flexible container (NDC 55150-243-46, Lot CLF160003, Expiry date May 2018).
The product has been found to contain visible particulate matter tentatively identified as mold. AuroMedics shipped the lot to customers nationwide from September 19 through October 31, 2017.
Posted 01/18/2018] AUDIENCE: Pharmacy, Risk Manager, Infectious Disease ISSUE: AuroMedics Pharma LLC is voluntarily recalling one lot of Levofloxacin in 5% Dextrose Injection 250mg/50mL in a Single-Use flexible container NDC 55150-243-46, Lot CLF160003, Expiry date May 2018, to the hospital level. The product has been found to contain visible particulate matter tentatively identified as mold.
Free Daily News
- FDA: Surgical mesh mini-slings comparable to mid-urethral slings for stress urinary incontinence
- Federal guidelines require written consent for pelvic exams at hospitals, medical schools
- Survey: More than half of ED nurses experienced violence in past month
- Heart transplant research proves out 24-hour organ preservation method
- Healthcare safety report: Outcomes improving, but workplace violence persists
- Annual CMS rules support underserved, under-resourced communities, promote value-based care
- Data resource details causes, health implications of sleep deprivation
- Medical error initiative from Joint Commission affiliate NQF targets preventable harm, “never events”
- EPA rule to limit dangerous emissions from medical sterilization plants
- Newly FDA-approved microsurgical system holds promise for training, new treatments